1927-nm Fractional resurfacing of facial actinic keratoses: A promising new therapeutic option - 14/12/12
Abstract |
Background |
Actinic keratoses (AK) are precancerous epidermal proliferations commonly present on chronically sun-damaged skin. These lesions are among the most often treated dermatologic conditions.
Objective |
We sought to investigate the 6-month safety, tolerance, and efficacy of nonablative 1927-nm fractional resurfacing of facial AK.
Methods |
This was a prospective clinical trial of 24 individuals with facial photodamage and AK receiving up to 4 treatments with the fractionated 1927-nm nonablative thulium laser.
Results |
At 6 months, an 86.6% reduction in absolute number of lesions was noted by independent physician assessment. In addition, at this same time point, patients reported marked or noticeable improvement in overall photodamage.
Limitations |
This prospective study does not provide safety, tolerance, and efficacy data beyond 6 months of follow-up, nor does it identify the precise mechanism of action involved in AK clearance after 1927-nm resurfacing.
Conclusion |
The clinical and histologic findings, as well as the reported patient satisfaction and safety, suggest that the treatment of AK and photodamage with a fractionated 1927-nm nonablative thulium laser is a promising new therapeutic option.
Le texte complet de cet article est disponible en PDF.Key words : actinic keratosis, laser, nonablative resurfacing, photodamage, rejuvenation
Plan
Funding sources: None. |
|
Disclosure: Drs Geronemus and Brightman are investigators with Solta Medical. Drs Weiss, Brauer, Anolik, Reddy, Karen, Hale, and Bernstein have no conflicts of interest to declare. |
Vol 68 - N° 1
P. 98-102 - janvier 2013 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?